Your Cart

First in-human study update – webcast presentation

First in-human study update – webcast presentation

You can also register to watch the entire Zoom webcast on-demand by clicking here

Related Articles

1H2023 Half-Year Results

1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.